Article
Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 1 Jan 2010
Butts Charles A, Ding Keyue, Seymour Lesley, Twumasi-Ankrah Philip, Graham Barbara, Gandara David, Johnson David H, Kesler Kenneth A, Green Mark, Vincent Mark, Cormier Yvon, Goss Glenwood, Findlay Brian, Johnston Michael, Tsao Ming-Sound, Shepherd Frances A
Abstract excerpt
PURPOSE Adjuvant cisplatin-based chemotherapy (ACT) is now an accepted standard for completely resected stage II and III A non-small-cell lung cancer (NSCLC). Long-term follow-up is important to document persistent benefit and late toxicity. We report here updated overall survival (OS) and diseas...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.